(Q70379864)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

L Farde

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

F A Wiesel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

P Jansson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

G Uppfeldt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

A Wahlen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

G Sedvall

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

1-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00735871

10 October 2019

exact match

0 references

cites work

Plasma level monitoring of antipsychotic drugs. Clinical utility

1 reference

12 December 2020

Automated analysis of homovanillic acid and 5-hydroxyindole-3-acetic acid in biological fluids by coupled-column liquid chromatography and dual coulometric-amperometric detection

1 reference

12 December 2020

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

12 December 2020

Imaging dopamine receptors in the human brain by positron tomography.

1 reference

12 December 2020

Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

1 reference

12 December 2020

A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness

1 reference

12 December 2020

Imaging of neurotransmitter receptors in the living human brain

1 reference

12 December 2020

Time Course for Effects of Sulpiride and Chlorpromazine on Monoamine Metabolite and Prolactin Levels in Cerebrospinal Fluid from Schizophrenic Patients

1 reference

12 December 2020

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

12 December 2020

Development of a schizophrenia scale sensitive to change

1 reference

12 December 2020

Zetidoline, a new antipsychotic. First controlled trial in acute schizophrenia

1 reference

12 December 2020

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

12 December 2020

Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients

1 reference

12 December 2020

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

12 December 2020

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

12 December 2020

Clinical Evaluation of Sulpiride in Schizophrenic Patients - A Double-blind Comparison with Chlorpromazine

1 reference

12 December 2020

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

1 reference

12 December 2020

The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.

1 reference

12 December 2020

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1 reference

12 December 2020

Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography

1 reference

12 December 2020

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.

1 reference

12 December 2020

No D2 receptor increase in PET study of schizophrenia

1 reference

12 December 2020

A Double‐Blind Comparison of Sulpiride with Chlorpromazine in Chronic Schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00735871

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3126517%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference